Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed Tomography

• Published in: Gut and liver Vol. 16; no. 3; pp. 474 - 482
• Main Authors: Sung Woo Ko, Tae Hyeon Kim, Tae Jun Song, Seong-hun Kim, Dong-wan Seo, Jai Hoon Yoon, Chang Min Cho, Jae Hee Cho, Jun-ho Choi, Dong Wook Lee, Sang Hyub Lee, Seung Bae Yoon, Tae Hoon Lee, Gwang Ha Kim, Hoon Jai Chun
• Format: Journal Article
• Language: Korean
• Published: 대한간학회 30.05.2022
• Subjects: Endosonography; Kaplan-Meier estimate; Pancreatic neoplasms
• ISSN: 1976-2283

Background/Aims: Endoscopic ultrasonography (EUS) provides high-resolution images and is superior to computed tomography (CT) scan in diagnosing small pancreatic ductal adenocarcinoma (PDAC). As a result, the use of EUS for early detection of PDAC has attracted attention. This study aimed to identify the clinical and radiological characteristics of patients with PDAC diagnosed by EUS but not found on CT scan. Methods: The medical records of patients diagnosed with PDAC at 12 tertiary referral centers in Korea from January 2003 to April 2019 were reviewed. This study included patients with pancreatic masses not clearly observed on CT scan but identified on EUS. The clinical characteristics and radiological features of the patients were analyzed, and survival analysis was performed. Results: A total of 83 patients were enrolled. The most common abnormal CT findings other than a definite mass was pancreatic duct dilatation, which was identified in 61 patients (73.5%). All but four patients underwent surgery. The final pathologic stages were as follows: IA (n=31, 39.2%), IB (n=8, 10.1%), IIA (n=20, 25.3%), IIB (n=17, 21.5%), III (n=2, 2.5%), and IV (n=1, 1.4%). The 5-year survival rate of these patients was 50.6% (95% confidence interval, 38.8% to 66.7%). Elevated liver function testing and R1 resection emerged as significant predictors of mortality in the multivariable Cox regression analysis. Conclusions: This multicenter study demonstrated favorable long-term prognosis in patients with PDAC diagnosed by EUS but indeterminate on CT scan. EUS should be considered for patients with suspected PDAC but indeterminate on CT scan. (Gut Liver 2022;16:474-482)